Re CannPal Animal Therapeutics Ltd

The applicants, CannPal Animal Therapeutics Limited, a company incorporated under the Corporations Act 2001, applied to the court for orders convening a scheme meeting, seeking approval of a proposed scheme of arrangement under Part 2F.1 of the Corporations Act. The respondents, the company's shareholders, contested the application on the basis that the statutory requirements for convening a scheme meeting were not satisfied. The case was heard in the Federal Court of Australia, presided over by Justice Edelman.

The primary legal issue before the court was whether the requirements to order a scheme meeting under section 411(1) of the Corporations Act were met. The applicants had to demonstrate that the court was satisfied that the proposed scheme of arrangement was fair and reasonable to all parties affected by it and that the necessary disclosures had been made. The respondents argued that the applicants had not adequately discharged this burden, primarily due to concerns about the disclosure of the scheme's financial details and the fairness of the proposed terms to minority shareholders.

The court considered the evidence and submissions from both parties. Justice Edelman found that the applicants had provided sufficient information to satisfy the statutory requirements. The court noted that while there were some imperfections in the disclosure, these did not undermine the overall fairness of the scheme. The respondents' arguments regarding the lack of disclosure were addressed and found to be unconvincing. Consequently, the court concluded that the applicants had met the necessary criteria under section 411(1) of the Corporations Act and ordered that a scheme meeting be convened to allow shareholders to vote on the proposed scheme.

In light of the court's decision, orders were made convening the scheme meeting, enabling the company to proceed with the proposed scheme of arrangement. The court directed that the meeting be held on a specified date and provided detailed instructions regarding the manner in which the meeting was to be conducted, including the procedures for shareholder voting and the notice requirements.